These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 14764635)

  • 1. Interaction of tumor necrosis factor-alpha- and thiazolidinedione-regulated pathways in obesity.
    Wellen KE; Uysal KT; Wiesbrock S; Yang Q; Chen H; Hotamisligil GS
    Endocrinology; 2004 May; 145(5):2214-20. PubMed ID: 14764635
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Role of skeletal muscle in thiazolidinedione insulin sensitizer (PPARgamma agonist) action.
    Zierath JR; Ryder JW; Doebber T; Woods J; Wu M; Ventre J; Li Z; McCrary C; Berger J; Zhang B; Moller DE
    Endocrinology; 1998 Dec; 139(12):5034-41. PubMed ID: 9832442
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of prepartum 2,4-thiazolidinedione on insulin sensitivity, plasma concentrations of tumor necrosis factor-α and leptin, and adipose tissue gene expression.
    Schoenberg KM; Perfield KL; Farney JK; Bradford BJ; Boisclair YR; Overton TR
    J Dairy Sci; 2011 Nov; 94(11):5523-32. PubMed ID: 22032375
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The beneficial metabolic effects of insulin sensitizers are not attenuated by mitochondrial pyruvate carrier 2 hypomorphism.
    Vigueira PA; McCommis KS; Hodges WT; Schweitzer GG; Cole SL; Oonthonpan L; Taylor EB; McDonald WG; Kletzien RF; Colca JR; Finck BN
    Exp Physiol; 2017 Aug; 102(8):985-999. PubMed ID: 28597936
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dynamic changes of adiponectin and S100A8 levels by the selective peroxisome proliferator-activated receptor-gamma agonist rivoglitazone.
    Hiuge-Shimizu A; Maeda N; Hirata A; Nakatsuji H; Nakamura K; Okuno A; Kihara S; Funahashi T; Shimomura I
    Arterioscler Thromb Vasc Biol; 2011 Apr; 31(4):792-9. PubMed ID: 21233451
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Functional analysis of tumor necrosis factor (TNF) receptors in TNF-alpha-mediated insulin resistance in genetic obesity.
    Uysal KT; Wiesbrock SM; Hotamisligil GS
    Endocrinology; 1998 Dec; 139(12):4832-8. PubMed ID: 9832419
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Protection from obesity-induced insulin resistance in mice lacking TNF-alpha function.
    Uysal KT; Wiesbrock SM; Marino MW; Hotamisligil GS
    Nature; 1997 Oct; 389(6651):610-4. PubMed ID: 9335502
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Alterations of the classic pathway of complement in adipose tissue of obesity and insulin resistance.
    Zhang J; Wright W; Bernlohr DA; Cushman SW; Chen X
    Am J Physiol Endocrinol Metab; 2007 May; 292(5):E1433-40. PubMed ID: 17244723
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A new selective peroxisome proliferator-activated receptor gamma antagonist with antiobesity and antidiabetic activity.
    Rieusset J; Touri F; Michalik L; Escher P; Desvergne B; Niesor E; Wahli W
    Mol Endocrinol; 2002 Nov; 16(11):2628-44. PubMed ID: 12403851
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Increased adipose tissue expression of Grb14 in several models of insulin resistance.
    Cariou B; Capitaine N; Le Marcis V; Vega N; Béréziat V; Kergoat M; Laville M; Girard J; Vidal H; Burnol AF
    FASEB J; 2004 Jun; 18(9):965-7. PubMed ID: 15059968
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Mechanisms of thiazolidinedione derivatives for hypoglycemic and insulin sensitizing effects].
    Sugiyama Y; Murase K; Ikeda H
    Nihon Rinsho; 2000 Feb; 58(2):370-5. PubMed ID: 10707560
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antidiabetic effect of a novel non-thiazolidinedione PPAR gamma/alpha agonist on ob/ob mice.
    Hu X; Feng Y; Shen Y; Zhao XF; Yu JH; Yang YS; Leng Y
    Acta Pharmacol Sin; 2006 Oct; 27(10):1346-52. PubMed ID: 17007742
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of troglitazone on tumor necrosis factor alpha and transforming growth factor beta expression and action in human adipocyte precursor cells in primary culture.
    Skurk T; Birgel M; Lee YM; Hauner H
    Metabolism; 2006 Mar; 55(3):309-16. PubMed ID: 16483873
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of insulin-sensitising agents in mice with hepatic insulin resistance.
    Cohen SE; Tseng YH; Michael MD; Kahn CR
    Diabetologia; 2004 Mar; 47(3):407-411. PubMed ID: 14730378
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antidiabetic thiazolidinediones block the inhibitory effect of tumor necrosis factor-alpha on differentiation, insulin-stimulated glucose uptake, and gene expression in 3T3-L1 cells.
    Szalkowski D; White-Carrington S; Berger J; Zhang B
    Endocrinology; 1995 Apr; 136(4):1474-81. PubMed ID: 7895657
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Subtherapeutic dose of pioglitazone reduces expression of inflammatory adipokines in db/db mice.
    Mohapatra J; Sharma M; Singh S; Chatterjee A; Swain P; Balaraman R; Patel PR; Jain MR
    Pharmacology; 2009; 84(4):203-10. PubMed ID: 19738399
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mechanisms of TNF-alpha-induced insulin resistance.
    Hotamisligil GS
    Exp Clin Endocrinol Diabetes; 1999; 107(2):119-25. PubMed ID: 10320052
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The effect of PPARgamma ligands on the adipose tissue in insulin resistance.
    Hammarstedt A; Andersson CX; Rotter Sopasakis V; Smith U
    Prostaglandins Leukot Essent Fatty Acids; 2005 Jul; 73(1):65-75. PubMed ID: 15936183
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Anti-inflammatory effects of troglitazone in nondiabetic obese subjects independent of changes in insulin sensitivity.
    van Tits LJ; Arioglu-Oral E; Sweep CG; Smits P; Stalenhoef AF; Tack CJ
    Neth J Med; 2005; 63(7):250-5. PubMed ID: 16093575
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Thiazolidinediones block tumor necrosis factor-alpha-induced inhibition of insulin signaling.
    Peraldi P; Xu M; Spiegelman BM
    J Clin Invest; 1997 Oct; 100(7):1863-9. PubMed ID: 9312188
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.